SOX5 promotes breast cancer proliferation and invasion by transactivation of EZH2
Authors:
Open Access
- 9 January 2019
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (3) , 2754-2762
Abstract
Sex determining region Y‑box protein 5 (SOX5) is a transcriptional factor and serves important roles in various cancer types; however, the pathological role of SOX5 in patients with breast cancer remains unclear. In the present study, the expression and potential role of SOX5 in patients with breast cancer and in breast cancer cells was investigated. The data indicated that SOX5 was highly expressed in breast cancer tissues compared with adjacent healthy tissues, and overexpression of SOX5 was associated with a reduced overall survival rate in patients with breast cancer. Gain and loss of function studies with MTT, colony formation, wound healing and Matrigel invasion assays demonstrated that SOX5 significantly promoted breast cancer cell proliferation and invasion. The chromatin immunoprecipitation (ChIP) assay sequence, quantitative ChIP and luciferase reporter assays were used to identify enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) as a downstream target gene of SOX5. Furthermore, it was determined that ectopic expression of SOX5 increased EZH2 expression at the mRNA and protein level, while the knockdown of SOX5 decreased EZH2 expression. Additionally, the biological effect of SOX5 was investigated, and it was determined to be dependent on the regulation of EZH2 expression. The present results may provide important insights into the biological significance of SOX5 serving as a candidate therapeutic target in breast cancer progression.Keywords
This publication has 27 references indexed in Scilit:
- Dysregulated Recruitment of the Histone Methyltransferase EZH2 to the Class II Transactivator (CIITA) Promoter IV in Breast Cancer CellsPLOS ONE, 2012
- The molecular pathology of breast cancer progressionThe Journal of Pathology, 2010
- SOX5 controls cell cycle progression in neural progenitors by interfering with the WNT–β‐catenin pathwayEMBO Reports, 2010
- A Sox5 gene is expressed in the myogenic lineage during trout embryonic developmentThe International Journal of Developmental Biology, 2010
- Breast Cancer Metastasis: Challenges and OpportunitiesCancer Research, 2009
- DNA fingerprinting tags novel altered chromosomal regions and identifies the involvement of SOX5 in the progression of prostate cancerInternational Journal of Cancer, 2009
- MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98GCancer Letters, 2008
- Transcription factor SOX‐5 enhances nasopharyngeal carcinoma progression by down‐regulating SPARC gene expressionThe Journal of Pathology, 2007
- EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsProceedings of the National Academy of Sciences, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001